Reference intervals of Cyfra21-1 and CEA in healthy adult Han Chinese population

• Published in: Practical laboratory medicine Vol. 40; p. e00409
• Main Authors: Xing, Lidan, Zhao, Shuai, Gao, Shichao, Shi, Xiaoqian, Huang, Yaomeng, Bian, Puhuan, Sun, Jingna
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.05.2024; Elsevier
• Subjects: CEA; Cyfra21-1; Healthy adults; Lung cancer; Reference interval; Registered Report Stage II; Healthy adults; Reference interval; Cyfra21-1; Lung cancer; CEA
• ISSN: 2352-5517; 2352-5517
• DOI: 10.1016/j.plabm.2024.e00409

This study aimed to establish the reference intervals of Cyfra21-1 and CEA for the local screening populations using a chemiluminescence method. A total of 4845 healthy adults and 190 lung cancer patients were included from the First Hospital of Hebei Medical University. The levels of Cyfra21-1 and CEA were measured to establish the local reference intervals. The upper limit reference intervals for Cyfra21-1 and CEA were determined as 3.19 ng/ml and 3.13 ng/ml, respectively. Notably, both Cyfra21-1 and CEA levels were found to be higher in males than in females. Additionally, both biomarkers showed an increasing trend with age. In terms of diagnostic efficacy, the receiver operating characteristic (ROC) curve areas for Cyfra21-1, CEA, and their combination in lung cancer were 0.86, 0.73, and 0.91, respectively. Our study revealed that the reference intervals of Cyfra21-1 and CEA in the local population differed from the established reference intervals. Furthermore, both biomarkers exhibited gender-dependent variations and demonstrated a positive correlation with age. Combining the two biomarkers showed potential for improving the diagnosis rate of lung cancer.